Prescribing practice with cognition enhancers in outpatient case: - Are there differences regarding type of dementia? Results of a representative survey in lower Saxony, Germany

Pharmacopsychiatry

Volumn 29, Issue 4, 1996, Pages 150-155

  Stoppe, Gabriela ^a   Sandholzer, H ^a   Staedt, J ^a   Winter, Silke ^a   Kiefer, J ^a   Ruther E ^a  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; DIHYDROERGOTOXINE; GINKGO BILOBA EXTRACT; NAFTIDROFURYL; NICERGOLINE; NIMODIPINE; NOOTROPIC AGENT; PENTOXIFYLLINE; PIRACETAM; PYRITINOL;

ADULT; ALZHEIMER DISEASE; ARTICLE; COGNITION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PHYSICIAN; PRESCRIPTION; PRIORITY JOURNAL; QUESTIONNAIRE; SENILE DEMENTIA;

EID: 0030036454     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979562     Document Type: Article

References (68)

1. APA - American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders. 3rd Edition, Revised (DSM-III-R). Washington: American Psychiatric Association (1987)
2. Arrigo, A., R. Casale, I. Giorgi, C. Guarnaschelli, F. Zelaschi: Effects of intravenous high dose co-dergocrine mesylate ("Hydergine") in elderly patients with severe multi-infarct dementia; a double-blind, placebo-controlled trial. Curr. Med. Res. Opin. 11 (Suppl. 8) (1989) 491-500
3. Babikian V., A. H. Ropper: Binswanger's disease: A review. Stroke 18 (1987) 2-12
4. Ban, T. A., L. Morey, E. Aguglia, O. Azzarelli, F. Balsano, V. Marigliano, N. Caglieris, M. Sterliccio, A. Capurso, N. A. Tomasi: Nimodipine in the treatment of old age dementias. Prog. Neuropsychopharmacol. Biol. Psychiatry 14 (Suppl. 4) (1990) 525-551
5. Besson, J. A. O., A. F. Palin, K. P. Abmeier, J. M. Eagles, F. W. Smith: Calcium antagonists and multi-infarct-dementia: A trial involving sequential NMR and psychometric assessment. Int. J. Geriatr. Psychiatry 3 (1988) 99-105
6. Black, R. S., L. L. Barclay, K. A. Nolan, H. T. Thaler, S. T. Hardiman, J. P. Blass: Pentoxifylline in cerebrovascular dementia. J. Am. Geriatr. Soc. 40 (1992) 237-244
7. Boller, F., O. L. Lopez, J. Moossy: Diagnosis of dementia. Clinicopathologic correlations. Neurology 39 (Suppl. 1) (1989) 76-79
8. Canadian Cooperative Study Group: A randomized trial of aspirin and sulfinpyrazone in patients with TIA. N. Engl. J. Med. 299 (1978) 53-59
9. Chatellier, G., L. Lacomblez: on behalf of Groupe Francais d'Étude de la Tetrahydroaminoacridine: Tacrine (tetrahydroaminoacridine; THA) and lecithine in senile dementia of the Alzheimer's type. A multicentre trial. Br. Med. J. 300 (1990) 495-499
10. Croisile, B., M. Trillet, J. Fondarai, B. Laurent, F. Mauguière, M. Billardon: Longterm and high-dose piracetam treatment of Alzheimer's disease. Neurology 43 (1993) 301-305
11. de Jonge, M.C., J. Traber: Nimodipine: cognition, aging, and degeneration. Clin-Neuropharmacol. 16 (Suppl. 1) (1993) 25-30
12. Evans, D.: Estimated prevalence of Alzheimer's disease in the United States. Milbank Q. 68 (1990) 267-289
13. Davis, K. L., L. J. Thal, E. Gamzu: Tacrine in patients with Alzheimer's disease: a double-blind, placebo-controlled multicenter study. N. Engl. J. Med. 327 (1992) 1253-1259
14. Erkinjuntti, T., M. Haltia, R. Sulkava, A. Paetan: Accuracy of the clinical diagnosis of vascular dementia: A prospective clinical and post-mortem neuropathological study. J. Neurol. Neurosurg. Psychiatry 51 (1988) 1037-1044
15. Farlow, M., S. I. Gracon, L. A. Hershey, K. W. Lewis, C. H. Sadowsky, B. S. N. Dolan-Ureno, for the Tacrine Study Group: A controlled trial of tacrine in Alzheimer's disease. JAMA 268 (1992) 2523-2529
16. Fisch, H. U.: Soziopharmakologie - am Beispiel der Psychopharmaka. Schweiz Med. Wschr. 109 (1979) 461-466
17. Fischhof, P. K., B. Saletu, E. Rüther, G. Litschauer, R. Möslinger-Gehmayr, W. M. Herrmann: Therapeutic efficacy of pyritinol in patients with senile dementia of the Alzheimer type (SDAT) and Multi-infarct Dementia (MID). Neuropsychobiology 26 (1992) 65-70
18. Forette, F., F. Boller: Hypertension and the risk of dementia in the elderly. Am. J. Med. 90 (Suppl. 3A) (1991) 14-19
19. Fröstl, W., L. Maitre: The families of cognition enhancers. Pharmacopsychiat. 22 (1989) 54-100
20. Gottfries, C. G.: Pharmacological treatment strategies in dementia disorders. Pharmacopsychiat. 22 (1989) 129-134
21. Grossmann, W. M., A. Standl, U. May, H. H. van Laak, H. Hirche: Naftidrofuryl in the treatment of mild senile dementia. A double-blind study. Pharmacopsychiat. 23 (Suppl. 6) (1990) 265-273
22. Hachinski, V. C., L. D. Iliff, E. Zilkha, G. A. duBoulay, J. Marshall, R. W. Ross Russell: Cerebral blood flow in dementia. Arch. Neurol. 32 (1975) 632-637
23. Harfmann, A.: Comparative randomized study of cerebral blood flow after long-term adminisitration of pentoxifylline and Codergocrine mesylate in patients with chronic cerebrovascular disease. Curr. Med. Res. Opin. 9 (1985) 475-479
24. Heiss, W. D., I. Hebold, P. Klinkhammer, P. Ziffling, B. Szelies, G. Pawlik, K. Herholz: Effect of piracetam on cerebral glucose metabolism in Alzheimer's disease as measured by positron emission tomography. J. Cereb. Blood Flow. Metab. 8 (Suppl. 4) (1988) 613-617
25. Heiss, W. D., B. Szelies, J. Kessler, K. Herholz: Abnormalities of energy metabolism in Alzheimer's disease studied with PET. Ann. N. Y. Acad. Sci. (1991) 65-71
26. Herrmann, W. M., K. Stephan: Moving from the question of efficacy to the question of therapeutic relevance: an exploratory reanalysis of a controlled clinical study of 130 inpatients with dementia syndrome taking piracetam. Int. Psychogeriatr. 4 (Suppl. 1) (1992) 25-44
27. Holt, W. S., S. A. Mazzucca: A written case stimulation of osteoarthritis as a predictor of prescribing behaviour among family practitioners. Acad. Med. 67 (1992) 414-415
28. Jarvik, L. F.: Calcium channel blocker nimodipine for primary degenerative dementia. Biol. Psychiatry 30 (1991) 1171-1174
29. Jones, T. V., M. S. Gerrity, J. Earp: Written case simulations: do they predict physician's behavior? J. Clin. Epidemiol. 43 (1990) 805-815
30. Kalaria, R. N.: The blood-brain barrier and cerebral microcirculation in Alzheimer's disease. Cerebrovasc. Brain Metab. Rev. 4 (1992) 226-260
31. Kan, J. P.: Current and future approaches to therapy of Alzheimer's disease. Eur. J. Med. Chem. 27 (1992) 565-570
32. Konowski, S., P. Fischhof, R. Hiersemenzel, J. Röhmel, U. Kern: Wirksamkeitsnachweis von Nootropika am Beispiel von Nimodipin - ein Beitrag zur Entwicklung geeigneter klinischer Prüfmodelle. Zeitschr. Gerontopsychol. & -psychiatr. 1 (1988) 35-44
33. Kleijnen, J., P. Knipschild: Ginkgo biloba. Lancet 340 (1992) 1136-1139
34. Kukull, W. A., E. B. Larson, B. V. Reifler, T. H. Lampe, M. Yerby, J. Hughes: The validity of 3 clinical diagnostic criteria for Alzheimer's disease. Neurology 40 (1990) 1364-1369
35. Ladurner, G., P. Erhart, C. Erhart, V. Schreiber: Therapie des hirnorganischen Psychosyndroms in täglicher Einmalgabe. Wien. klin. Wschr. 103 (1991) 8-14
36. Laporte, J. R., D. Capella: Useless drugs are no placebos: lessons from flunarizine and cinnarizine. Lancet ii (1986) 853-854
37. Lipowski, Z. J.: Delirium: Acute Confusional States. New York: Oxford University Press, 1990
38. Mangoni, A. M., P. Grassi, L. Fratola, R. Piolti, S. Bassi, A. Motta, A. Marcone, S. Smirne: Effects of a MAO-B inhibitor in the treatment of Alzheimer disease. Eur. Neurol. 31 (1991) 100-107
39. Max, W.: The economic impact of Alzheimer's disease. Neurology 43 (Suppl. 4) (1993) 6-10
40. Mazzucca, S. A., K. D. Brandt, S. L. Anderson, B. S. Musick, B. P. Katz: Therapeutic approaches of community based practitioners to osteoarthritis of the hip in an elderly patient. J. Rheumatol. 18 (1991) 1593-1600
41. McKhann, G., D. Drachmann, M. Folstein, R. Katzman, D. Price, E. M. Stadlan: Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology 34 (1984) 939-944
42. Meyer, J. S., B. W. Judd, T. Tawaklna, R. L. Rogers, K. F. Mortel: Improved cognition after control of risk factors for multi-infarct-dementia. J. Am. Med. Ass. 256 (1986) 2203-2209
43. Meyer, J. S., R. L. Rogers, K. McClintic, K. F. Mortel, J. Lofti: Randomized clinical trial of daily aspirin therapy in multi-infarct dementia. A pilot study. J. Am. Geriatr. Soc. 37 (1989) 549-555
44. Milvio, C.: Dihydroergocristin bei der Behandlung des hirnorganischen Psychosyndroms. Dosis-Findungs-Studie gegen Plazebo. Arzneimittelforschung 42 (Suppl. 11A) (1992) 1399-1402
45. Montamat, S. C., B. J. Cusack, R. E. Nestal: Management of drug therapy in the elderly. N. Engl. J. Med. 321 (1989) 303-309
46. Nolan, L., K. O'Malley: Prescribing for the elderly: Part I. Sensitivity of the elderly to adverse drug reactions. J. Am. Geriatr. Soc. 36 (1988) 142-149
47. Parnetti, L., C. Ciufetti, M. Mercuri, U. Senin: Hemorheological pattern in initial mental deterioration: results of a long-term study using piracetam and pentoxifylline. Arch. Gerontol. Geriatr. 4 (1985) 141-155
48. Parnetti, L., U. Senin, M. Carosi, H. Baasch: Mental deterioration in old age: results of two multicenter, clinical trials with nimodipine. The Nimodipine Study Group. Clin.-Ther. 15 (Suppl. 2) (1991) 394-406
49. Pincemail, J., M. Dupuis, C. Nasr, P. Hans, M. Haag-Berrurier, R. Anton, C. Deby: Superoxide anion scavenging effects and superoxide dismutase activity of Ginkgo biloba extract. Experientia 45 (Suppl. 8) (1989) 708-712
50. Rethans, J. J., F. Sturmans, R. Drop, V. D. C. Vleuten, P. Hobus: Does competence of general practitioners predict their performance? Comparison between examination setting and actual practice. Brit. Med. J. 303 (1991) 1377-1380
51. Roman, G. C., T. K. Tatemichi, T. Erkinjuntti, J. L. Cummings, J. C. Masdeu, J. H. Garcia, L. Amaducci, J. M. Orgogozo, A. Brun, A. Hofman, D. M. Moody, M. D. O'Brien, T. Yamaguchi, J. Grofman, B. P. Drayer, D. A. Bennett, M. Fisher, J. Ogata, E. Kokmen, F. Bermajo, P. A. Wolf, P. B. Gorelick, K. L. Bick, A. K. Pajeau, M. A. Bell, C. DeCarli, A. Culebras, A. D. Korzcyn, J. Bogousslavsky, A. Hartmann, P. Scheinberg: Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 43 (1993) 250-260
52. Rosen, W. G., R. D. Terry, P. A. Fuld, R. Katzman, A. Peck: Pathological verification of ischemic score in differentiation of dementias. Ann. Neurol. 7 (1979) 486-488
53. Saletu, B., J. Grunberger: Memory dysfunction and vigilance: neurophysiological and psychopharmacological aspects. Ann. N. Y. Acad. Sci. 444 (1985) 406-427
54. Saletu, B., I. Hochmayer, J. Grunberger, F. Bohmer, J. Paroubek, L. Wicke, A. Neuhold: Zur Therapie der Multiinfarktdemenz mit Nicoergolin 1: Doppelblinde, klinische, psychometrische und EEG-Imaginguntersuchungen mit 2 Dosierungsschemata. Wien. Med. Wochenschr. 137 (Suppl. 22) (1987) 513-524
55. Scarzella, L., G. Bono, B. Bergamasco: Dihydroergocryptine in the management of senile psycho-organic syndrome. Int. J. Clin. Pharmacol. Res. 12 (Suppl.) (1992) 37-46
56. Scheibel, A. B., T. Duong, U. Tomiyasu: Denervation microangiopathy in senile dementia, Alzheimer type. Alzheimer Dis. Assoc. Disord. 1 (Suppl. 1) (1987) 19-37
57. Schwabe, U., D. Paffrath (eds.): Arzneiverordnungs-Report '93. Stuttgart: Gustav Fischer, 1993
58. Stoppe, G., H. Sandholzer, J. Staedt, J. Kiefer, S. Winter, E. Rüther: Ambulante Behandlung von Schlafstörungen im Alter. Dtsch. Med. Wschr. 119 (1994a) 1538-1542
59. Stoppe, G., H. Sandholzer, J. Staedt, S. Winter, J. Kiefer, M. M. Kochen, E. Rüther: Diagnosis of dementia in primary care: Results of a representative survey in Lower Saxony, Germany. Eur. Arch. Psychiatry Clin. Neurosci. 244 (1994b) 278-283
60. Stoppe, G., H. Sandholzer, J. Staedt, J. Kiefer, S. Winter, M. M. Kochen, E. Rüther: Einflußfaktoren auf die Verordnung von Nootropika. Ergebnisse einer repräsentativen Umfrage in Niedersachsen, Dtsch. med. Wschr. 120 (1995) 1614-1619
61. Tariot, P. N., T. Sunderland, H. Weingartner, D. L. Murphy, J. A. Welkowitz, K. Thompson, R. M. Cohen: Cognitive effects of L-Deprenyl in Alzheimer's disease. Psychopharmacology (Berlin) 91 (1987) 489-495
62. Thienhaus, O. J., B. G. Wheeler, S. Simon, F. P. Zemlan, J. T. Hartford: A controlled double-blind study of high-dose dihydroergotoxine mesylate (Hydergine) in mild dementia. J. Am. Geriatr. Soc. 35 (Suppl. 3) (1987) 219-223
63. Tierney, M. C., R. H. Fisher, A. J. Lewis, M. L. Zorzitto, W. G. Snow, D: W. Reid, P. Nieuwstraten: The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: A clinicopathologic study of 57 cases. Neurology 38 (1988) 359-364
64. Vernon, M. W., E. M. Sorkin: Piracetam. An overview of its pharmacological properties and a review of its therapeutic use in senile cognitive disorders. Drugs Aging 1 (Suppl. 1) (1991) 17-35
65. Vinters, H. V.: Cerebral amyloid angiopathy. A critical review. Stroke 18 (1987) 311-324
66. Whalley, L. J.: Drug treatments of dementia. Brit. J. Psychiatry 155 (1989) 595-611
67. WHO - World Health Organization: Tenth revision of the Internation Classification of diseases, Chapter V (F): Mental and Behavioural Disorders (including disorders of psychological development). Clinical Descriptions and Diagnostic guidelines. Geneva: WHO, 1991
68. Witte, S., I. Anadere, E. Walitza: Verbesserung der Hamorheologie durch Ginkgo-biloba-Extrakt. Verminderung eines kardiovaskulären Risikofaktors. Fortschr. Med. 110 (Suppl. 13) (1992) 247-250